Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
about
Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix lamininPoxvirus cell entry: how many proteins does it take?Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansStructural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 proteinStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcriptionVaccinia virus L2 protein associates with the endoplasmic reticulum near the growing edge of crescent precursors of immature virions and stabilizes a subset of viral membrane proteinsThe product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.Congregation of orthopoxvirus virions in cytoplasmic A-type inclusions is mediated by interactions of a bridging protein (A26p) with a matrix protein (ATIp) and a virion membrane-associated protein (A27p)The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinA novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranesThe membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsPoxvirus multiprotein entry-fusion complexEntry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entryVaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.Ligand-induced and nonfusogenic dissolution of a viral membrane.Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.Smallpox vaccines: targets of protective immunity.The structure of G4, the poxvirus disulfide oxidoreductase essential for virus maturation and infectivity.The envelope G3L protein is essential for entry of vaccinia virus into host cellsVaccinia virus entry into cells via a low-pH-dependent endosomal pathway.Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.Lipid membranes in poxvirus replication.Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.Antiviral activity of the EB peptide against zoonotic poxviruses.Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pHAssociation of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.Two distinct low-pH steps promote entry of vaccinia virus.Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cellsOrthopoxvirus species and strain differences in cell entry.Immunity and immunological memory following smallpox vaccination.Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum.Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.Vaccinia virus l1 protein is required for cell entry and membrane fusion.Vaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodiesExpression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.Vaccinia virus strain differences in cell attachment and entry.
P2860
Q24336532-7E34EC33-D2AE-4108-A798-72A74F19EDDAQ27002455-ADDAA069-7EB3-4042-AA16-482B14F02F6BQ27488704-031ACE7A-44D9-4972-808F-0028B4EA2BD2Q27647102-4B0AADE9-55B3-49D4-BDFB-78B803557135Q27679281-77710EDD-9BC5-471E-BF9B-37821942D752Q28477161-E67E23E4-6C8B-4124-96E5-29C07F9B6D6BQ28743094-3EFEA1FA-8FDC-454D-9278-647EC606A8EAQ33930439-0792DCE2-890C-48B6-BE03-FF2241C0E4FAQ33964058-4D94589C-00FB-48A6-A911-35DE848E0495Q34039477-5C449B18-23FF-4A07-AB71-22418C1B76A8Q34059600-B2185EF5-BBF4-4862-BE27-744D516CB6ABQ34109783-FAD7C68A-63D8-4C25-AC5E-9323C773A668Q34202362-CF1B9BEB-9A8C-4984-BEF3-137DCCE55506Q34233115-AE313FBD-B55C-4652-9F6D-BE846994FC8EQ34259469-E7EEA48B-344E-4852-83F3-76161E789B16Q34434835-17EB2AAB-04C2-46BF-8D52-F9BDED233051Q34507126-2C2033B4-614A-49E9-80B2-31591868B544Q34778139-6F048EB8-E9B6-44A9-8713-A093CCA89310Q34780607-DE43063E-CD7D-48A7-B11A-5F98FDD49983Q35023719-261508E2-6CD0-4E7B-BF69-12910A628C12Q35024119-968F7E9B-F544-418C-BB8E-F4FBF066C40AQ35024254-5DBABFBD-C9E6-42F7-A7B4-FDE2C9247A38Q35101363-71595652-32E2-4B68-BF14-B929F1C88D24Q35101454-E324055A-4B4D-40AE-84C7-C572C53ED6C0Q35260919-9B06616B-AC7D-4E45-B3B1-7C427185AFC5Q35665944-2C9F96BB-E192-4A82-A666-BBEB4A283CAEQ35744848-EE2A02ED-F712-4637-8B96-5500A501D58EQ35826881-4A15AC12-F127-4683-860B-2D027307EB2DQ35857238-D381B17E-4AEE-4965-8275-43716235ADFCQ35947676-D64407AD-70E6-4047-931E-A014E2D71A74Q36103310-D863689F-11E3-4299-9109-B0D35BE5F967Q36315941-832D7FB6-F6C3-4329-AEDB-CDA718D63E50Q36529039-2E254E7C-BB6C-4009-814F-9A364DCEAE38Q36559826-0EE47085-8130-4B5D-ACC8-86D7C138D204Q36673363-8D1446D1-03A7-4B91-A75C-05969958D5B1Q36747975-8DA64A05-E436-457A-B2BA-A2863F572F41Q36845831-7B6AB401-6924-4BFD-B2A4-A58A8B1A9CC4Q37066691-46E321AC-6394-48BD-BC71-CF38CC260884Q37099872-4E0DD526-984C-44DB-B864-C53C1EBE69DDQ37238558-D2BCE9F8-562B-40E6-8882-758D75B6BE06
P2860
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@ast
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@en
type
label
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@ast
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@en
prefLabel
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@ast
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@en
P2860
P1433
P1476
Vaccinia virus A21 virion membrane protein is required for cell entry and fusion
@en
P2093
Alan C Townsley
Tatiana G Senkevich
P2860
P304
P356
10.1128/JVI.79.15.9458-9469.2005
P50
P577
2005-08-01T00:00:00Z